ON-TREATMENT LDL-C LEVELS WHEN ALIROCUMAB DOSE IS DECREASED FROM 150 TO 75 MG EVERY 2 WEEKS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM ODYSSEY
1998 ◽
Vol 31
(2)
◽
pp. 55A
2019 ◽
Vol 73
(9)
◽
pp. 1715
◽
2020 ◽
2021 ◽
Vol 77
(18)
◽
pp. 1411
2017 ◽
Vol 27
(1)
◽
pp. e4-e5